MedTrace Logo

Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis

NCT00728598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2008-08-06

No results posted yet for this study

Summary

Fractalkine (FKN) is a chemoattractant and adhesion molecule for leukocytes. Angiogenic effect of FKN also has been reported. We investigate FKN-mediated angiogenesis in ocular angiogenic disorders.

Conditions

  • Proliferative Diabetic Retinopathy
  • Angiogenesis

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chang-Hao Yang, MD, PhD · Ophthalmology, National Taiwan University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-31
Primary Completion
1998-12-31
Completion
1998-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00728598 on ClinicalTrials.gov